It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
For >70 years, a 4-fold or greater rise in antibody titer has been used to confirm influenza virus infections in paired sera, despite recognition that this heuristic can lack sensitivity. Here we analyze with a novel Bayesian model a large cohort of 2353 individuals followed for up to 5 years in Hong Kong to characterize influenza antibody dynamics and develop an algorithm to improve the identification of influenza virus infections. After infection, we estimate that hemagglutination-inhibiting (HAI) titers were boosted by 16-fold on average and subsequently decrease by 14% per year. In six epidemics, the infection risks for adults were 3%–19% while the infection risks for children were 1.6–4.4 times higher than that of younger adults. Every two-fold increase in pre-epidemic HAI titer was associated with 19%–58% protection against infection. Our inferential framework clarifies the contributions of age and pre-epidemic HAI titers to characterize individual infection risk.
Serological classification of influenza infection has classically been based on a four-fold or higher increase in antibody levels, but this approach may not be optimal. Here, the authors develop a Bayesian model to improve identification of infections in serological samples by accounting for individual antibody dynamics.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Ip, Dennis K. M. 3 ; Malik Peiris, J. S. 2
; Leung, Gabriel M. 1
; Cowling, Benjamin J. 1
; Cauchemez, Simon 4 1 The University of Hong Kong, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, Hong Kong Special Administrative Region, China (GRID:grid.194645.b) (ISNI:0000000121742757); Hong Kong Science and Technology Park, Laboratory of Data Discovery for Health Limited, New Territories, Hong Kong (GRID:grid.194645.b)
2 The University of Hong Kong, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, Hong Kong Special Administrative Region, China (GRID:grid.194645.b) (ISNI:0000000121742757); The University of Hong Kong, HKU-Pasteur Research Pole, Hong Kong Special Administrative Region, China (GRID:grid.194645.b) (ISNI:0000000121742757)
3 The University of Hong Kong, WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Shing Faculty of Medicine, Hong Kong Special Administrative Region, China (GRID:grid.194645.b) (ISNI:0000000121742757)
4 Mathematical Modelling of Infectious Diseases Unit, Institut Pasteur, UMR2000, CNRS, Paris, France (GRID:grid.428999.7) (ISNI:0000 0001 2353 6535)




